Potential targets for antiviral therapy of HDV include drugs that interfere with postranslational modification and viral assembly. New drugs, such as prenylation inhibitors, HBV entry inhibitors, and new forms of interferons are currently being studied and tested for the treatment of hepatitis D, with better efficacy and tolerability.
Hepatitis D future or investigational therapies
Hepatitis B future or investigational therapies
Hepatitis E future or investigational therapies
Hepatitis C future or investigational therapies
Hepatitis E primary prevention
Hepatitis C primary prevention
Hepatitis B secondary prevention
Hepatitis B primary prevention